General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Redondo P et al. – The findings suggest that angiogenic, coagulation and endothelial damage/dysfunction markers are possibly linked in pathogenesis of extensive slow–flow vascular malformations, and might have therapeutic implications.

Related Articles

Calpain Inhibitor SNJ-1945 Attenuates Events Prior to Angiogenesis in Cultured Human Retinal Endothelial Cells
Journal of Ocular Pharmacology and Therapeutics, 11/09/09    Relevance Score: 69%

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
British Journal of Cancer, 10/26/09    Relevance Score: 66%

Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology, 10/16/09    Relevance Score: 66%

Treatment of brain metastases from renal cell cancer
Urologic Oncology: Seminars and Original Investigations, 10/27/09    Relevance Score: 64%

Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
Cancer Research, 10/21/09    Relevance Score: 64%

Today in Dermatology...keeping you current

Familial atypical cold urticaria: Description of a new hereditary disease
Journal of Allergy and Clinical Immunology, 11/25/09

Topical Calcipotriol for Preventive Treatment of Hypertrophic Scars
Archives of Dermatology, 11/25/09

Aquagenic Wrinkling of the Palms in Cystic Fibrosis
Archives of Dermatology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address